Top Markets
Coin of the day
Eucrates Biomedical Acquisition Corp. Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.

EUCR
Rangering i aksjer #26003
Eucrates Biomedical Acquisition Corp. currently lacks substantial business... Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe. Established in 2020, this entity has its headquarters situated in New York, New York.
Aksjekurs
$10.04
Sist synkronisert: 2023-05-05
Markedsverdi
$44.29M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Eucrates Biomedical Acquisition Corp. (EUCR)
P/B-forhold for Eucrates Biomedical Acquisition Corp. (EUCR)
P/B-forhold per 2026 TTM: 0
Ifølge Eucrates Biomedical Acquisition Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Eucrates Biomedical Acquisition Corp. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter